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Abstract and key words 25 
In an investigator-blind, randomised cross-over design, male well-trained cyclists (n=20) completed four 26 
experimental trials.  Each trial consisted of a 2h constant load ride (185 ± 25W) followed by a work-matched 27 
time trial task (~35min).  Three commercially available CHO beverages, plus a control (water), were 28 
administered during the 2h ride providing  0, 20, 39 or 64g CHO/h at a fluid intake rate of 1L·h-1.   29 
Performance was assessed by time to complete the time trial task, mean power output sustained, and pacing 30 
strategy used. Mean task completion time (min:sec ± SD) for 39g·h-1 (34:19.5 ± 03:07.1, p=0.006) and 31 
64g·h-1 (34:11.3 ± 03:08.5 p=0.004) of CHO were significantly faster than control (37:01.9 ± 05:35.0).  The 32 
mean percentage improvement from control was -6.1% (95% CI: -11.3 to -1.0) and -6.5% (95% CI: -11.7 33 
to -1.4) in the 39 and 64g·h-1 trials respectively.  The 20g·h-1 (35:17.6 ± 04:16.3) treatment did not reach 34 
statistical significance compared to control (p = 0.126) despite a mean improvement of -3.7% (95% CI -8.8 35 
to 1.5%).  Mean power output differences mirrored the performance time.  There was no interaction between 36 
CHO dose and pacing strategy. 39 and 64g·h-1 of CHO were similarly effective at improving endurance 37 
cycling performance compared to a 0g·h-1 control in our well trained cyclists.   38 




Introduction   41 
Carbohydrate (CHO) intake during exercise has consistently been shown to improve exercise performance 42 
(Smith et al., 2013; Smith et al., 2010) and extend exercise capacity (Galloway & Maughan, 2000; Watson, 43 
Shirreffs, & Maughan, 2012).  CHO is thought to act in many ways to enhance performance: sparing of 44 
muscle glycogen (Bjorkman, Sahlin, Hagenfeldt, & Wahren, 1984; Stellingwerff et al., 2007); enhancing 45 
and maintaining elevated CHO oxidation rate; maintenance of blood glucose concentration (Coyle, Coggan, 46 
Hemmert, & Ivy, 1986);  elevated exogenous CHO oxidation rate (Galloway, Wootton, Murphy, & 47 
Maughan, 2001); and central and peripheral neural up-regulation (Carter, Jeukendrup, & Jones, 2004; 48 
Chambers, Bridge, & Jones, 2009; Nikolopoulos, Arkinstall, & Hawley, 2004).  As a result, CHO feeding 49 
strategies are now widely employed in the exercise setting as a means to support athletic performance.   50 
Although the provision of CHO has been shown to improve exercise performance/capacity, the optimal 51 
dose of CHO required to maximise athletic performance remains a topic of debate.  Currently, guidelines 52 
from the ACSM state an optimal dose of CHO during exercise to be within the range of 30 - 60g.h-1.  53 
However, significant improvements in performance and exercise capacity have been reported with 54 
ingestion rates as low as 22g.h-1 (Galloway & Maughan, 2000; Maughan, Bethell, & Leiper, 1996) and as 55 
high as >100 g.h-1 (Currell & Jeukendrup, 2008) highlighting a beneficial impact of CHO ingestion over a 56 
much broader range of feeding rates, when compared with water or placebo solutions.  Smith et al (2010) 57 
indicated that 15, 30 and 60g.h-1 were all ‘very likely’ to improve power output sustained (7.4, 8.3 and 58 
10.7% respectively) during a 20km TT when compared to a 0g.h-1 placebo, with 60g.h-1 providing the largest 59 
effect.  Furthermore, 30g.h-1 was ‘very unlikely’ to further improve performance over 15g.h-1 whilst 60g.h-60 
1 was ‘likely’ to improve performance over the 30g·h-1 with a mean percentage improvement of only 2.3%.  61 
However, following post hoc power calculations, the authors indicated that a sample size of 15 to 22 was 62 
required to confidently conclude there were no differences in performances across the three doses. In 63 
contrast Watson et al (2012) reported no further improvements in time to exhaustion when feeding a 6% 64 
(~47g·h-1) mixed CHO solution when compared to a 4% (~27g.h-1) mixed solution.  The absence of an 65 
additional improvement with the higher CHO dose is surprising considering the improvements in 66 
performance reported with higher ingestion rates (Smith et al., 2010).   As such, it seems a range of CHO 67 
feeding doses increases performance over a 0g·h-1 condition.  However, any additional increases in CHO 68 




To provide clarity to the optimal dose of CHO for performance additional studies with greater sample sizes 71 
have followed up these initial reports.  In a recent study Smith et al (2013) expanded on these data and 72 
examined fifty five participants spread across four sites. The participants consumed CHO during a 2h 73 
submaximal ride followed by a 20km TT task.   Each participant completed 4 trials, one placebo and three 74 
CHO treatments, between 10 and 120g·h-1 (10g·h-1 increments) which consisted of a 1:1:1 ratio of glucose, 75 
fructose and maltodextrin. Following some statistical modelling of their data the authors reported an 76 
optimal dose of 78g·h-1 for performances during the TT.  However, they reported only a small 1.7% 77 
improvement in performance from 30 to 80g·h-1, and a rather trivial 0.7% improvement in performance 78 
from 40 to 80g·h-1.  In addition, the linear regression model used for the determination of the optimal 79 
feeding strategy utilised was not significant.  Taken together, these studies suggest increasing amounts of 80 
CHO result in diminishing returns with respect to performance gains.  81 
These data, coupled with those of Smith et al (2010) and Watson et al (2012), indicate a divide between the 82 
optimal feeding rates and compositions reported by investigators and the subsequent measurable and 83 
meaningful improvement in performance obtained from increasing amounts of CHO, particularly in the 30 84 
to 60g.h-1 range.  Similarly, the range of responses reported across the feeding rates provided in these studies 85 
highlights considerable individual variability.  Accordingly, the aim of the current study was to determine 86 
the dose response relationship between CHO feeding and exercise performance in the 0 to 64g.h-1 range in 87 
20 male cyclists.  Furthermore, pacing strategies used during a performance task were investigated to 88 
provide insight as to where any changes in performance may be the greatest.     89 
 90 
Methods 91 
Twenty well-trained male cyclists were recruited from regional cycling and triathlon clubs. The mean (± 92 
SD) characteristics of the participants were: age 34.0 (± 10.2) years, body mass 74.6 (± 7.9) kg, stature 93 
178.3 (± 8.0) cm, peak power output (PPO) 393 (± 36) W, and VO2max 62 (± 9) ml·kg-1·min-1. Participants 94 
were required to have been training for >6 h / wk for >3 y. Each individual had the procedures and 95 
associated risks explained prior to providing written informed consent to participate in the study, which 96 




In an investigator blind, placebo controlled, randomised cross-over study design participants visited the 99 
laboratory 6 times (2 preliminary and 4 intervention) over a six week period.  They completed one visit per 100 
week commencing each trial on the same day at the same time of day on each visit.  Following pre-101 
screening, participants completed a preliminary assessment where lactate threshold, VO2max, and peak 102 
power output were determined and for the first familiarisation of the performance task to be used in 103 
subsequent visits.  On the second visit participants completed a full familiarisation trial.  The familiarisation 104 
trial and four subsequent intervention trials involved a 120 min steady submaximal cycle at 95% lactate 105 
threshold (184 ± 25W) followed by a time trial performance task, whereupon the participants were 106 
instructed to be complete their set work target as quickly as possible.  Water was ingested for the 107 
familiarisation trial and consumed at a rate of 1 L·h-1.  Thereafter, on the intervention trials participants 108 
consumed in a random order either:  a control (water) 0%, 2%, 3.9% or 6.4% CHO solutions, in random 109 
order, at a fluid ingestion rate of 1L·h-1.  Performance was determined as the time to complete a work 110 
matched simulated time trial task designed to last ~30min.  Pacing strategy was assessed from taking time 111 
splits and average power output sustained for each 10% of work competed during the performance task. 112 
Preliminary testing 113 
On week 1 of 6, following a 10h overnight fast, participants performed a two section incremental cycle test 114 
(Lode Excalibur Sport, Netherlands) to determine maximal oxygen uptake (VO2max, lactate threshold, and 115 
peak power output. Section 1 commenced at 120W and each stage increased 30W every 3 min until blood 116 
lactate increased more than 2mmol·L between stages (lactate threshold defined as the final point before the 117 
blood lactate concentration increased distinctly from the baseline concentration (Aunola & Rusko, 1984).  118 
In the last 30 s of each stage, heart rate (Polar Electro, Finland) was recorded and a capillary blood sample 119 
(fingertip) was obtained for blood lactate concentration analysis by micro-assay (LactatePro LT-1710, 120 
ArkRay Inc., Kyoto, Japan).  The reliability and validity of this device has been previously determined 121 
(Pyne, Boston, Martin, & Logan, 2000).  This initial stage was followed by a 10 min recovery period.  122 
Individual lactate responses were examined independently by two researchers to ensure validity and 123 
consistency of the analysis. The mean ± SD lactate concentration at LT was 2.1 ± 0.4 mmol·L corresponding 124 
to an intensity of 52 ± 6% of PPO for LT which is typical of other studies utilising a similar protocol (Neal 125 
et al., 2013).  126 
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Participants commenced section 2, starting at an intensity of the penultimate stage of section 1, with each 127 
stage lasting 1 min and increased by 30 W until volitional exhaustion.  The end time and power output of 128 
the stage was used to calculate peak power output (PPO) using the following equation (Kuipers, 129 
Verstappen, Keizer, Geurten, & Van Kranenburg, 1985):   130 
PPO = Wfinal + ([t/60] ∙ PI) 131 
Where, Wfinal = the power output of the final completed stage in (watts), t = the time spent in the final 132 
uncompleted stage (seconds), 60 = the duration of each stage (seconds) and PI = the increase in power 133 
output between each stage (W).  Maximal oxygen uptake (VO2max) was also measured during this protocol 134 
via an automated online gas analysis machine (Oxycon Pro, Jaeger, Wuerzerberg, Germany).  VO2max was 135 
determined as the highest average VO2 captured in a 30 sec period.   136 
Familiarisation and Experimental trials 137 
On arrival to the laboratory participants emptied bladder and bowel prior to nude body mass measurements.  138 
Individuals then changed into cycling attire which was kept consistent throughout all trials to reduce 139 
thermoregulatory variability.  Participants then completed a 2h submaximal ride at 95% LT (185 ± 25 W) 140 
during which one of four beverages were consumed: 0% water (familiarisation and control); 2.0%; 3.9%; 141 
or 6.4% glucose (single carbohydrate) based commercially available CHO beverage.  All beverages were 142 
maintained at 10°C and were consumed at a rate of 1L·h-1 providing 0, 20, 39 and 64g·h-1 of CHO 143 
respectively.  The 20g.h-1 solution contained 37mg of sodium per 100mL and the 39 and 64g·h-1 solutions 144 
both contained 50mg per 100mL.  Each beverage was provided with an initial bolus ingestion of 240 mL 145 
two minutes prior to the start of exercise.  Subsequently, 220mL was consumed every 15 min with the final 146 
drink provided at 120min of exercise.  Following the 2h ride, a 5min recovery period allowed a toilet break 147 
and for the equipment to be set up for the performance task.  The performance task was a work target 148 
simulated time trial specific to the individual (531 ± 48KJ).  A linear factor, 70% Wmax divided by preferred 149 
cadence (rpm2), was entered into the cycle ergometer. The formula used to determine the work target value 150 
was: 151 
Work target = (0.7 · PPO) · 1800 152 
The time trial protocol employed has previously been validated and has been shown to be highly reliable 153 




Data Presentation and Statistical analysis 156 
All data are presented as mean (±SD) unless otherwise stated.  Total time to complete the performance task 157 
and average power output sustained throughout were compared across all trials.  The magnitude of 158 
difference from the water control was examined with a one-way ANOVA with Dunnet’s post hoc 159 
comparisons made.  The mean differences between two variables are presented as the mean with associated 160 
95% confidence limits and Cohen’s size effects (mean difference; confidence intervals; Cohen’s size 161 
effects). Cohen’s sizes effects can be interpreted as 0.2 = small, 0.6 = moderate, 1.2 = large, 2.0 = very 162 
large and 4.0 = extremely large.  Performance task time and average power output was compared between 163 
treatments using repeated measures regression models.  The null hypothesis of no differences between any 164 
of the treatments groups was tested using ANOVA with all values compared back to the water control 165 
condition.  A difference from the control of 3.5% in either time to complete the task or mean power output 166 




Results  169 
Performance time and mean power output 170 
Mean task completion time (min:sec ± SD) for 39g·h-1 (34:19.5 ± 03:07.1, p<0.01) and 64g·h-1 (34:11.3 ± 171 
03:08.5, p<0.01) CHO solutions were significantly faster than control (37:01.9 ± 05:35.0) (Fig 1).  172 
Corresponding percentage change from the 0g·h-1condition was similar at 6.1% (95% CI 1 to 11.3%; 173 
p=0.02) for the 39g·h-1 trial, and 7% (95% CI 1 to 12%, p=0.01) for the 64g·h-1 trial (Fig. 2). The 20g·h-1 174 
(35:17.6 ± 04:16.3) treatment did not reach statistical significance compared to control (p=0.13) despite a 175 
mean improvement of 3.7% (95% CI -1.5 to 8.8%).  The Cohen’s size effect in comparison to the control 176 
was 0.6 (95% CI -0.1 to 1.4), 1.0 (95% CI 0.2 to 1.7), and 1.0 (95% CI 0.3 to 1.8) for 20, 39 and 64g·h-1 177 
treatments respectively indicating moderate and large effects on performance improvement.   178 
In conjunction, there was a significant effect of treatment on mean power output sustained during the time 179 
trial between the four experimental trials (p<0.01).  There were significant increases of 17W (95% CI 5-180 
30; p<0.01) and 19W (95% CI 6-31; p<0.01) in mean power output sustained throughout the 39g·h-1 and 181 
64g·h-1 treatments, respectively.  Corresponding percentage improvements compared to the 0 g·h-1 trial 182 
were similar at 8% (95% CI 1-15%; p=0.02) for the 39 g·h-1 trial, and 9% (95% CI 2-16%; p=0.01) for 183 
the 64g·h-1 trial.  There was no statistical difference reported between the 20g·h-1 treatment and the 0g·h-1 184 
control (p=0.12) despite a 5.7% (95% CI: -1.2 to 12.6) mean increase in power output sustained.  The 185 
Cohen’s size effect compared to the control was 0.7 (-0.1 to 1.4), 1.1 (0.3 to 1.8), and 1.1 (0.4 to 1.9) for 186 
20, 39 and 64g·h-1 reflecting moderate and large effects respectfully. 187 
 188 
Pacing strategy 189 
The assessment of pacing strategy revealed no interaction between time and treatment (p=0.80).  This 190 
suggests no evidence of any differences in the slopes of the lines between the treatments in the incremental 191 





This study was designed to determine the optimal dose of CHO to maximise endurance exercise 195 
performance.  We show that CHO provided at rates of 39 and 64g·h-1 were equally effective at improving 196 
performance in 20 well trained male participants compared to a 0g·h-1 water control.  The 20g·h-1 treatment 197 
did not, on average, show evidence of a significant improvement in participants’ performance, despite 198 
demonstrating a meaningful mean improvement in both performance task time and mean power output over 199 
the 0g·h-1 treatment.  As such, our data demonstrate that a plateau in performance gain occurs when 200 
consuming a single source CHO beverage at rates between 39 to 64g·h-1 during endurance tasks lasting less 201 
than 3hrs. 202 
Previous studies investigating a dose-response relationship between CHO feeding and endurance exercise 203 
performance/capacity have reported somewhat conflicting results.  Smith et al (2010) provided evidence of 204 
a dose-response relationship when feeding glucose in the range of 15 to 60g·h-1.  These authors showed 205 
that all trials significantly improved performance of 12 cyclists over the placebo condition, with only the 206 
60g·h-1 ‘likely’ to improve performance over the 15g·h-1.  However, the authors highlighted that 15-22 207 
participants would be required to make meaningful comparisons between solutions, leaving no clear picture 208 
into the optimal dose of CHO.  In a follow up investigation, Smith et al (2013) reported that optimal 209 
performance gains with CHO ingestion were likely to occur at rates as high as 78g·h-1 when consuming 210 
multiple forms of CHO.  However, the optimal dose for the greatest improvement in performance was 211 
unclear in the 40 to 80g·h-1 range and interpretation is limited by the choice of study design. In contrast, 212 
Watson et al (2012) observed no further improvement in exercise capacity when 46g·h-1 was consumed 213 
compared to 31g·h-1 during prolonged exercise in cool conditions.  We add to these data by demonstrating 214 
that the vast majority of the performance gains occur when ingesting 39 g·h-1 with greater amounts of CHO 215 
ingestion (64 g·h-1) providing negligible additional performance gains.  As such, these results support the 216 
hypothesis that a ceiling in performance gains exists when consuming CHO above 40g.h-1 during exercise 217 
< 3 h.  However, any mechanistic explanation for the outcome would only be speculative due to the limited 218 
measures taken throughout the trial: though increased neural drive through oral sensors in the mouth; better 219 
maintenance of blood glucose due to greater exogenous glucose availability; enhanced maintenance of 220 




Consuming 20g·h-1 of CHO in the present study had a less easily interpretable outcome.  When participants 223 
consumed 20g·h-1 performance did not significantly improve over the water control, while 39 or 64g·h-1 of 224 
CHO did not significantly differ compared to 20g·h-1.  Other investigations have reported a significant 225 
improvement in performance and/or exercise capacity with quite modest (~15g·h-1) amounts of CHO when 226 
compared to a 0g·h-1 condition (Galloway & Maughan, 2000; Karelis et al., 2010; Maughan et al., 1996; 227 
Murray, Seifert, Eddy, Paul, & Halaby, 1989).  Consuming 20g·h-1 in the present study still produced a 228 
mean improvement in performance time of 3.7% compared to 0g.h-1, which corresponds to a ~58s reduction 229 
in time trial task time.  The variance in response is a likely explanation for lack of statistical significance, 230 
but it is noteworthy that there is considerable variation in performance responses in all CHO conditions, 231 
not just at the 20g.h-1.  Additionally, some individuals (n=2) did not respond positively to any of the CHO 232 
ingestion trial, with the control condition being the fastest trial completed.  The variability in performances, 233 
along with some negative responses to CHO ingestion, highlights the individual nature of CHO feeding as 234 
an ergogenic aid. 235 
 236 
The range of responses measured in the present study highlights that, for the majority of individuals, there 237 
is a ceiling in the performance gains achieved when feeding rates are higher than 40g.h-1.  Any additional 238 
performance gains reported appear to result in a minimal increase in performance. However, in elite level 239 
athletes, there is evidence there is an enhanced ability to utilise CHO and have a subsequent meaningful 240 
improvement in performance (Stellingwerff, 2012).  In support of this enhanced intake Prof. Louise Burke 241 
(personal communication) has recently presented a case study describing a nutritional intervention which 242 
enabled an Olympic walker to ingest as much as 90g·h-1 of multiple transportable CHO.   Thus, when 243 
providing feeding recommendations, the degree to which an increase in performance translates into a 244 
worthwhile change should be considered.   245 
 246 
One potential limitation of the current investigation is that participants completed the trial following an 247 
overnight fasted to best control and replicate the metabolic state in which they arrive at the laboratory.  248 
Overnight fasting is not the current practice for optimal performance for athletes as liver glycogen is 249 
reduced following glycogen breakdown in the liver to maintain blood glucose concentrations overnight.  250 
However, the glycogen storage capacity of the liver is enhanced following endurance training therefore 251 
reducing the impact an overnight fast has on liver glycogen content.  Casey et al (2000) reported athletes 252 
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had an overnight liver glycogen content of 386mmol·L-1, which is considerably higher than values reported 253 
in healthy untrained individuals (~120 to 210mmol·L-1) (Magnusson, Rothman, Katz, Shulman, & 254 
Shulman, 1992; Stadler et al., 2013; Taylor et al., 1996).  Therefore, the liver glycogen content of athletes 255 
following an overnight fast is unlikely to vastly affect subsequent exercise performance.  In studies 256 
examining the effect of CHO on performance following a shorter (~3h) fast, where liver glycogen content 257 
is unlikely to be compromised, Hulston and Jeukendrup (2009) reported a significant improvement in 258 
performance when consuming a CHO beverage compared to water.  Additionally, a recent meta-analysis 259 
indicated the pre exercise nutritional status of participants (fed or fasted) appears to have no effect on the 260 
subsequent exercise performance/capacity achieved (Temesi, Johnson, Raymond, Burdon, & O’Connor, 261 
2011).  As such, the findings of this study are still likely to be applicable to those looking to perform in the 262 
fed state.   263 
 264 
The current investigation only measured performance responses up to feeding rates of 64g·h-1 and we are 265 
therefore unable to determine responses to higher feeding rates.  The upper feeding rate was based on 266 
research showing a maximal absorption rate of ~1g·min-1 of a single source CHO solution (A. E. Jeukendrup 267 
et al., 1999).  Nevertheless, we cannot be certain that CHO feeding rates above 64g·h-1 does not significantly 268 
alter subsequent performances as others have reported (Currell & Jeukendrup, 2008; Smith et al., 2013).  269 
The lack of any further substantial improvement in performance with rates >39g.h-1 in the present study, in 270 
addition to reports of a negative impact on performance with higher rates of CHO ingestion, suggests that 271 
performance is unlikely to improve with higher rates of single source CHO ingestion during exercise < 3h.  272 
Future studies should focus on utilising measures and techniques to try and ascertain explanations as to 273 
why some feeding rates are more beneficial than others, and which factors contribute to individual 274 
variability in response.   275 
 276 
Conclusions 277 
The 39g·h-1 and 64g·h-1 CHO solutions were equally effective in improving the cycling performance of 20 278 
well trained male cyclists over a 0g·h-1 water placebo following a 2 h submaximal ride.  For most well 279 
trained individuals, an optimal feeding rate for maximising the ergogenic effect of CHO for endurance 280 
performance is likely to occur at around 40g·h-1.  There is a wide range of responses to all rates of CHO 281 
12 
 
ingested highlighting the individual nature of the responses observed in individuals using CHO to aid 282 
performance.  However, the results of this study highlight that most individuals will respond most positively 283 
to CHO ingestion rates around 39 and 64g.h-1. 284 
 285 
Novelty statement 286 
The vast majority of performance improvement with CHO ingestion occurred when ingesting 39 g.h-1, with 287 
any additional CHO intake (64 g.h-1) providing a minimal additional performance gain.  As such, both 39 288 
and 64g.h-1 of carbohydrate, ingested during 2 hours of endurance exercise, are equally effective at 289 
improving subsequent TT task performance in comparison to a water control.  290 
 291 
Practical application 292 
Cyclists performing tasks lasting between 2-3 hours should consider consuming around 40-60g·h-1 of single 293 
source carbohydrate and increase their intake within this range depending on individual comfort and 294 
experience.   295 
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Figure 1.  Mean performance task time when 0, 20, 39, and 64 g·h-1 of carbohydrate were 408 
consumed with an arbitrary finish line denoting the fasting mean time.    Data presented 409 
as mean ± standard deviation. Statistical significance is (*p < 0.05).   410 
 411 
Figure 2. Percentage change in mean performance task time from the 0 g·h-1 treatment for 412 
20, 39, and 64 g·h-1 carbohydrate ingestion rates.  The percentage change in performance 413 
task time was significantly greater in the 39 g·h-1 and 64 g·h-1 trials when compared to 0 414 
g·h-1 (*p < 0.05). Data presented as mean ± 95% confidence intervals. 415 
 416 
Figure 3. Mean power output (A) and time to complete each 10% of the performance 417 
task (B) when 0 g·h-1 (-●-), 20 g·h-1 (- -), 39 g·h-1 (-○-), and 64 g·h-1 (-*-) of 418 
carbohydrate was consumed.  Data presented as means with the pooled standard error of 419 
the mean (open triangle) on an arbitrary value of 310 (Power) and 250 (Time) for ease 420 
of viewing.   421 
 422 
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